Zobrazeno 1 - 10
of 46
pro vyhledávání: '"силденафил"'
Autor:
S. A. Musashaykhova, Z. S. Valieva, A. K. Osokina, I. Z. Korobkova, V. V. Gramovich, N. M. Danilov, T. V. Martynyuk
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 74-81 (2022)
Modern pathogenetic therapy of idiopathic pulmonary arterial hypertension (IPAH), a severe life-threatening cardiovascular disease of unknown etiology, leads to a positive clinical effect due to reverse remodeling of the vessels of the microvasculatu
Externí odkaz:
https://doaj.org/article/c863d9d7f08d4d9791a8af2cbbb45589
Clinical case of a patient with pulmonary capillary hemangiomatosis: rapid progression or lost time?
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 74-78 (2021)
The article describes a clinical case of a 37-year-old patient with pulmonary capillary hemangiomatosis of functional class IV according to the WHO classification with difficulties of diagnostic search and features of PAH-specific therapy.Pulmonary a
Externí odkaz:
https://doaj.org/article/a351369002a048cc9b6da6b0748e36ca
Publikováno v:
Медицинский совет, Vol 0, Iss 5-6, Pp 78-82 (2019)
Легочная артериальная гипертензия — редкое и тяжелое заболевание, характеризующееся прогрессирующим повышением легочного сосудистог
Externí odkaz:
https://doaj.org/article/24d88f285d854219a42c27ff62c9f890
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 63, Iss 5, Pp 167-171 (2018)
Idiopathic pulmonary arterial hypertension is a progressive, incurable disease of unclear etiology; it is characterized by intensive remodeling of the pulmonary vascular bed with a predominant lesion of the distal pulmonary arteries and arterioles. A
Externí odkaz:
https://doaj.org/article/d491a2a178ac465499e292e8d2847e00
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 48-59 (2018)
PAH associated with CHD according to the Russian Register of Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is highly prevalent and ranks second after idiopathic pulmonary hypertension (IPH) in terms o
Externí odkaz:
https://doaj.org/article/1631418e767d4863a2a9809266d36803
Autor:
T. V. Martynyuk, Z. H. Dadacheva, V. M. Paramonov, M. A. Saidova, S. N. Nakonechnikov, I. Ye. Chazova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 32-43 (2017)
Aim: to study the efficacy of sildenafil therapy in pulmonary hypertension of different etiology, its influence on the clinical, functional, hemodynamic status, structure and function of the right and left heart, right ventricular-arterial coupling (
Externí odkaz:
https://doaj.org/article/d059e6305f424c449a099157b05af8e6
Autor:
I. R. Gaisin, L. V. Richkova, A. S. Gazimzyanova, О. N. Larina, N. I. Maximov, A. A. Galimova, V. N. Gureeva, S. А. Pomosov, Е. G. Shirobokova, A. А. Ponomareva, M. B. Nikolaeva, L. V. Shilina, L. V. Ivanova, M. Yu. Zhuykova, N. N. Maximov, I. V. Bogdanova, N. N. Chechetova, D. V. Timonin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 16, Iss 1, Pp 82-90 (2017)
Aim. To assess the efficacy of regional system of multidisciplinary care in pulmonary hypertension (PH).Material and methods. In a single-center, pro and retrospective cohort study, 2001-2015, the epidemiological characteristics and yearly mortality
Externí odkaz:
https://doaj.org/article/9928ae0e5bd74caa976725284efab7d5
Autor:
Elisaveta Levunlieva, Anna Kaneva, Reneta Lekova, Kiparisiya Nenova-Karakasheva, Lyubomir Dimitrov
Publikováno v:
Bulgarian Cardiology 28(1): 120-134
При физиологична корекция тип Fontan на комплексни вродени сърдечни малформации (ВСМ) с общокамерна хемодинамика липсва субпулмонална кам
Publikováno v:
Rossijskij Vestnik Perinatologii i Pediatrii, Vol 59, Iss 6, Pp 93-97 (2016)
The paper describes the clinical use of a phosphodiesterase 5 inhibitor (sildenafll) in a patient with primary pulmonary hypertension during a long-term controlled follow-up. The 6-year use of sildenafll as monotherapy for pulmonary hypertension had
Externí odkaz:
https://doaj.org/article/d60d60c242d240c499dd0ffeb523afe8
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 15, Iss 1, Pp 51-57 (2016)
Aim. To assess clinical and hemodynamic efficacy of sildenafil at the background of basic therapy in patients with idiopathic and right ventricular (RV) dilated cardiomyopathy. Material and methods. Totally, 59 patients with idiopathic DCMP included.
Externí odkaz:
https://doaj.org/article/cbcc3db7803848f58f8d8d32031ebe03